Search

Your search keyword '"Kiley, Dana"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Kiley, Dana" Remove constraint Author: "Kiley, Dana"
62 results on '"Kiley, Dana"'

Search Results

1. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

2. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

3. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

4. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

5. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

6. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

7. De novo variants in DENND5B cause a neurodevelopmental disorder

8. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

9. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

10. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

11. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

12. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

13. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

14. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

15. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

16. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

17. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

18. De novo variants in DENND5B cause a neurodevelopmental disorder

19. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

20. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

21. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

22. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

23. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

24. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

25. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

26. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

27. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

28. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

29. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

30. One is the loneliest number: genotypic matchmaking using the electronic health record

31. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

32. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

33. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

34. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

35. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

36. Dominant missense variants in SREBF2are associated with complex dermatological, neurological, and skeletal abnormalities

37. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

38. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

39. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

40. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

41. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

42. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

43. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

44. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

45. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

46. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

47. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

48. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

49. Biallelic CRELD1variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

50. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

Catalog

Books, media, physical & digital resources